Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia

Leukemia. 2020 Oct;34(10):2785-2789. doi: 10.1038/s41375-020-0779-z. Epub 2020 Mar 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor
  • Exome Sequencing
  • Gene Expression Profiling
  • Genetic Testing
  • Genetic Therapy / adverse effects*
  • Genetic Therapy / methods
  • Genomics* / methods
  • Humans
  • Immunophenotyping
  • Neoplasms, Second Primary / diagnosis
  • Neoplasms, Second Primary / etiology*
  • Polymorphism, Single Nucleotide
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / etiology*
  • Wiskott-Aldrich Syndrome / complications
  • Wiskott-Aldrich Syndrome / genetics
  • Wiskott-Aldrich Syndrome / therapy

Substances

  • Biomarkers, Tumor